A Real-World Study on Ultrasound-Based Screening and Integrated Therapeutic Strategies for Patients With Concomitant Coronary and Cervicocephalic Artery Stenosis
NCT ID: NCT07034157
Last Updated: 2025-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2025-06-09
2026-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improved Image Quality for Assessment of Carotid Artery Stenosis by Ultrafast Ultrasound FLOW Imaging
NCT06170580
Progression Assessment of Carotid Artery Stenosis by Ultrafast Ultrasound Flow Imaging
NCT05270005
Carotid Ultrasound Sub-Study of the Familial Atherosclerosis Study-observational Study
NCT00976014
Carotid Artery Plaque Vulnerability Assessment Using Ultrafast Ultrasound Techniques
NCT05218421
Angiography-Derived FFR And IVUS for Clinical Outcomes in Patients With Coronary Artery Disease
NCT04397211
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1: PCI + Carotid Revascularization
Patients diagnosed with both coronary artery disease and significant carotid artery stenosis requiring intervention, who received both PCI and carotid revascularization.
Percutaneous Coronary Intervention
Coronary stenting performed as part of routine care for patients with coronary artery stenosis.
Cerebrovascular Intervention (CAS ）
Patients with intervention-indicated head and neck artery stenosis will receive carotid artery stenting based on clinical evaluation.
Group 2: PCI + Observation of Carotid Stenosis
Patients who underwent PCI for coronary artery disease, with no carotid stenosis or with carotid stenosis not requiring or not receiving interventional treatment.
Percutaneous Coronary Intervention
Coronary stenting performed as part of routine care for patients with coronary artery stenosis.
No Intervention / Observation
Clinical observation or standard follow-up in patients without significant disease
Group 3: Observation Only (No PCI + No CAS)
Patients who did not undergo PCI and either had no carotid artery stenosis or were managed medically for carotid stenosis without any revascularization.
No Intervention / Observation
Clinical observation or standard follow-up in patients without significant disease
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Percutaneous Coronary Intervention
Coronary stenting performed as part of routine care for patients with coronary artery stenosis.
Cerebrovascular Intervention (CAS ）
Patients with intervention-indicated head and neck artery stenosis will receive carotid artery stenting based on clinical evaluation.
No Intervention / Observation
Clinical observation or standard follow-up in patients without significant disease
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with coronary artery disease scheduled to undergo elective percutaneous coronary intervention (PCI) on the following day.
Exclusion Criteria
2. Simultaneously merge other serious diseases;
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Anzhen Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiaochuan Huo
Prof
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Anzhen Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KS2025006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.